¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
Àν¶¸° º¸°ü ±â±â ½ÃÀå ¼ºÀå°ú µ¿Çâ
Grand View Research ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°èÀÇ Àν¶¸° º¸°ü ±â±â(Insulin Storage Devices) ½ÃÀå ±Ô¸ð´Â 2030³â 16¾ï 2,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö 8.08%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ´ç´¢º´ ȯÀÚ ÀÌȯÀ²ÀÌ Áõ°¡Çϰí Àν¶¸° º¸°ü ±â±â ¼ö¿ë¼ºÀÌ È®´ëµÇ°í Á¦Ç°ÀÌ »ç¿ë È®´ë ´öºÐÀÔ´Ï´Ù. ÀûÀýÇÑ ¿ÂµµÀÇ Àν¶¸° º¸°ü Çʿ伺 Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» Áö¿øÇÏ´Â Áß¿ä ¿ä¼ÒÀÔ´Ï´Ù. ¸ðµç Àν¶¸°Àº ³Ê¹« ³ô°Å³ª ³Ê¹« ³·Àº ¿Âµµ¿¡ ¹Î°¨Çϱ⠶§¹®¿¡ ÀúÀå Àåºñ°¡ ¸¹ÀÌ ÇÊ¿äÇÕ´Ï´Ù.
Áö³ ¼ö½Ê³â µ¿¾È Á¤Á¦ ¹× °¡°ø ½Äǰ ÀαⰡ ±ÞÁõÇÏ¸é¼ ¼ÒºñÀÚ °Ç°¿¡ ¾Ç¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ´ç´¢º´Àº ½Ä»ýȰÀ̳ª »ýȰ½À°ü È¥¶õ¿¡ ÀÇÇØ ü³» Àν¶¸° ³óµµ¸¦ Á¶ÀýÇÒ ¼ö ¾ø°Ô µÊÀ¸·Î½á ¹ßº´ÇÕ´Ï´Ù. ±× °á°ú, Á¤Á¦, °¡°ø ½Äǰ ¼Òºñ·® Áõ°¡³ª »ýȰ ½À°ü º¯È¿¡ ÀÇÇØ ´ç´¢º´ ÀÌȯÀ²ÀÌ Áõ°¡Çϸç, ¿¹»óµÇ´Â ±â°£ Áß Àν¶¸° º¸°ü ±â±â ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÇöÀç ÀúÀå ¿É¼ÇÀº ´Ü¿ Æ÷Àå°ú ÈÞ´ë¿ë ³ÃÀå°í»ÓÀÔ´Ï´Ù. ¿Âµµ °æº¸, ¸¸·á °æ°í, º¹¿ë·® ¾Ë¸², ÀÚµ¿ ¸Þ½ÃÁö Àü¼Û µî ¼Ó¼ºÀ» °®Ãá ½º¸¶Æ® ÀúÀå ½Ã½ºÅÛ Ãâ½Ã°¡ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÃßÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àν¶¸° º¸°ü ±â±â ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Á¦Ç° À¯Çüº°·Î´Â ¹èÅ͸®Çü ±â±â°¡ 2022³â 61.08%·Î ÃÖ°í ¸ÅÃâ Á¡À¯À²À» ȹµæÇß½À´Ï´Ù. È޴뼺°ú Á¤È®ÇÑ ³Ã°¢ ±â´ÉÀ¸·Î Àν¶¸° ¹ÙÀ̾Ë, Ææ ¹× īƮ¸®Áö ¿Âµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÒ ¼ö ÀÖÀ¸¹Ç·Î ´ç´¢º´ ȯÀÚµé »çÀÌ¿¡¼ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
- ȯÀÚ À¯Çüº°·Î´Â 1Çü ´ç´¢º´ ºÎ¹®ÀÌ 2022³â 81.8%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â Àν¶¸° ¿ä±¸°¡ ³ô¾ÆÁ® Àü´Þ ½Ã½ºÅÛÀ» ¼±È£ÇÏ°Ô µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù.
- ÃÖÁ¾ ¿ëµµº°·Î´Â À¯´ÉÇÑ ÀÇ·á Àü¹®°¡¿Í Àü¹®°¡¸¦ º¸À¯ÇÑ º´¿ø ºÎ¹®ÀÌ 2022³â 47.91% ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ºÏ¹Ì´Â 2022³â 45.67%·Î ÃÖ´ë ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
- Á¤º¸ Á¶´Þ
- Á¤º¸ ¶Ç´Â µ¥ÀÌÅÍ ºÐ¼®
- ½ÃÀå ¹üÀ§¿Í ºÎ¹® Á¤ÀÇ
- ½ÃÀå ¸ðÇü
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Àν¶¸° º¸°ü ±â±â ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- ¸ð ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ÃËÁø ¿äÀÎ ºÐ¼®
- ½ÃÀå ¾ïÁ¦ ¿äÀÎ ºÐ¼®
- ½ÃÀå ±âȸ ºÐ¼®
- Àν¶¸° º¸°ü ±â±â ½ÃÀå ºÐ¼® Åø
- Æ÷ÅÍÀÇ 5¼¼·Â ºÐ¼®
- PESTEL ºÐ¼®
- COVID-19 °¨¿° ¿µÇ⠺м®
Á¦4Àå Á¦Ç° À¯Çü ºñÁî´Ï½º ºÐ¼®
- Àν¶¸° º¸°ü ±â±â ½ÃÀå : Á¦Ç° À¯Çü º¯µ¿ ºÐ¼®
- ÀüÁö½Ä ŰƮ
- ÀüÁö½Ä ŰƮ ½ÃÀå(2018-2030³â)
- ´Ü¿ ŰƮ
- Àν¶¸° ³Ã°¢ Áö°©
- ³Ã°¢ ÆÄ¿ìÄ¡
- ´Ü¿ ³Ã°¢ °¡¹æ
Á¦5Àå ȯÀÚ À¯Çü ºñÁî´Ï½º ºÐ¼®
- Àν¶¸° º¸°ü ±â±â ½ÃÀå : ȯÀÚ À¯Çü º¯µ¿ ºÐ¼®
- 1Çü ´ç´¢º´
- 2Çü ´ç´¢º´
Á¦6Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®
- Àν¶¸° º¸°ü ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
- º´¿ø
- Àü¹® Ŭ¸®´Ð
- ÀçÅà Äɾî
Á¦7Àå Áö¿ª ºñÁî´Ï½º ºÐ¼®
- Áö¿ªº° Àν¶¸° º¸°ü ±â±â ½ÃÀå Á¡À¯À²(2022-2030³â)
- ºÏ¹Ì
- SWOT ºÐ¼®
- ºÏ¹Ì Àν¶¸° º¸°ü ±â±â ½ÃÀå(2018-2030³â)
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- SWOT ºÐ¼®
- À¯·´ Àν¶¸° º¸°ü ±â±â ½ÃÀå(2018-2030³â)
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- SWOT ºÐ¼®
- ¾Æ½Ã¾ÆÅÂÆò¾ç Àν¶¸° º¸°ü ±â±â ½ÃÀå(2018-2030³â)
- ÀϺ»
- Áß±¹
- Àεµ
- È£ÁÖ
- ű¹
- Çѱ¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- SWOT ºÐ¼®
- ¶óƾ¾Æ¸Þ¸®Ä« Àν¶¸° º¸°ü ±â±â ½ÃÀå(2018-2030³â)
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- SWOT ºÐ¼®
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Àν¶¸° º¸°ü ±â±â ½ÃÀå(2018-2030³â)
- ³²¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï »óȲ
- ±â¾÷ ºÐ·ù
- Àü·« ¸ÅÇÎ
- ±â¾÷ ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â)
- ±â¾÷ ÁÖ¿ä ¿ä¾à, ¸®½ºÆ®Ç¥
- ReadyCare, LLC
- DISONCARE
- Medicool
- Cooluli, Arkray, Inc.
- Arkray, Inc.
- Zhengzhou Olive Electronic Technology Co. Ltd.
- Zhengzhou Defrigus Electric Device Co., LtdC
- COOL Sarl-FR
- Godrej Appliances
NJH 23.09.06
Insulin Storage Device Market Growth & Trends
The global insulin storage device market size is expected to reach USD 1.62 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 8.08% from 2023 to 2030. The primary factors driving the growth are the rising incidence of diabetes patients and the expanding acceptability and increased utilization of goods for insulin storage devices. The growing need for insulin storage at a proper temperature is another important driver propelling the market's growth. Storage devices are highly sought after since all insulins are sensitive to temperatures that are either too high or too low.
The enormous increase in the popularity of refined and processed foods over the past few decades has negatively impacted consumer health. Diabetes is caused by poor dietary and lifestyle habits that interfere with the body's ability to control its insulin levels. As a result, it is predicted that the incidence of diabetes will grow due to rising consumption of refined and processed foods and changing lifestyle habits, driving up demand for insulin storage devices throughout the course of the anticipated timeframe.
Currently, the only storage options are insulated packaging and portable refrigerators. The launch of smart storage systems with attributes like temperature alerts, expiration warnings, dose reminders, and auto messaging is expected to boost the growth of the market over the forecast period.
Insulin Storage Device Market Report Highlights
- By product type, battery-operated devices captured the highest revenue share of 61.08% in 2022 due to their portability and precise chilling capabilities, which maintains the temperature of insulin vials, pens, and cartridges at a constant level, they are becoming more and more popular among diabetics
- By patient type, the type 1 diabetes sector had the largest market share of 81.8% in 2022, due to their increasing requirement for insulin and preference for delivery systems
- By end-use, the hospitals segment held the largest market share of 47.91% in 2022 as they possess competent medical professionals and specialists
- North America held the largest revenue share of 45.67% in 2022
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information Or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Insulin Storage Device Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of diabetes
- 3.2.1.2. Rise in the number of geriatric patients
- 3.2.1.3. Expanding governmental initiatives as well as technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of products
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Improvement in healthcare infrastructure in developing economies
- 3.3. Insulin Storage Device Market Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Type Business Analysis
- 4.1. Insulin Storage Device Market: Product Type Movement Analysis
- 4.2. Battery-Operated Kits
- 4.2.1. Battery Operated Kits Market, 2018 - 2030 (USD Million)
- 4.3. Insulated Kits
- 4.3.1. Insulin Cooling Wallets
- 4.3.1.1. Insulin Cooling Wallets Market, 2018 - 2030 (USD Million)
- 4.3.2. Cooling Pouches
- 4.3.2.1. Cooling Pouches Market, 2018 - 2030 (USD Million)
- 4.3.3. Insulated Cooling bags
- 4.3.3.1. Insulated Cooling Bags Market, 2018 - 2030 (USD Million)
Chapter 5. Patient Type Business Analysis
- 5.1. Insulin Storage Device Market: Patient Type Movement Analysis
- 5.2. Diabetes Type 1
- 5.2.1.1. Diabetes Type 1Market, 2018 - 2030 (USD Million)
- 5.3. Diabetes Type 2
- 5.3.1.1. Diabetes Type 2 Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
- 6.1. Insulin Storage Device Market: End-use Movement Analysis
- 6.2. Hospitals
- 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
- 6.3. Specialty Clinics
- 6.3.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
- 6.4. Homecare
- 6.4.1. Homecare Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Insulin Storage Device Market Share By Region, 2022 & 2030
- 7.2. North America
- 7.2.1. SWOT Analysis
- 7.2.2. North America Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.2.3. U.S.
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Target Disease Prevalence
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Regulatory Framework
- 7.2.3.5. Reimbursement Scenario
- 7.2.3.6. U.S. Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.2.4. Canada
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Target Disease Prevalence
- 7.2.4.3. Competitive Scenario
- 7.2.4.4. Regulatory Framework
- 7.2.4.5. Reimbursement Scenario
- 7.2.4.6. Canada Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. SWOT Analysis
- 7.3.2. Europe Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.3. UK
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Target Disease Prevalence
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Regulatory Framework
- 7.3.3.5. Reimbursement Scenario
- 7.3.3.6. UK Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.4. Germany
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Target Disease Prevalence
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. Regulatory Framework
- 7.3.4.5. Reimbursement Scenario
- 7.3.4.6. Germany Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.5. France
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Target Disease Prevalence
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Regulatory Framework
- 7.3.5.5. Reimbursement Scenario
- 7.3.5.6. France Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.6. Italy
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Target Disease Prevalence
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Regulatory Framework
- 7.3.6.5. Reimbursement Scenario
- 7.3.6.6. Italy Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.7. Spain
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Target Disease Prevalence
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Scenario
- 7.3.7.6. Spain Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.8. Denmark
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Target Disease Prevalence
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Regulatory Framework
- 7.3.8.5. Reimbursement Scenario
- 7.3.8.6. Denmark Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.9. Sweden
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Target Disease Prevalence
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Regulatory Framework
- 7.3.9.5. Reimbursement Scenario
- 7.3.9.6. Sweden Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.3.10. Norway
- 7.3.10.1. Key Country Dynamics
- 7.3.10.2. Target Disease Prevalence
- 7.3.10.3. Competitive Scenario
- 7.3.10.4. Regulatory Framework
- 7.3.10.5. Reimbursement Scenario
- 7.3.10.6. Norway Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. SWOT Analysis
- 7.4.2. Asia Pacific Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Regulatory Framework
- 7.4.3.5. Reimbursement Scenario
- 7.4.3.6. Japan Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4.4. China
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. Regulatory Framework
- 7.4.4.5. Reimbursement Scenario
- 7.4.4.6. China Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4.5. India
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Target Disease Prevalence
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Regulatory Framework
- 7.4.5.5. Reimbursement Scenario
- 7.4.5.6. India Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Target Disease Prevalence
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Scenario
- 7.4.6.6. Australia Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Target Disease Prevalence
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. Regulatory Framework
- 7.4.7.5. Reimbursement Scenario
- 7.4.7.6. Thailand Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.4.8. South Korea
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Target Disease Prevalence
- 7.4.8.3. Competitive Scenario
- 7.4.8.4. Regulatory Framework
- 7.4.8.5. Reimbursement Scenario
- 7.4.8.6. South Korea Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. SWOT Analysis
- 7.5.2. Latin America Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.5.3. Brazil
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Regulatory Framework
- 7.5.3.5. Reimbursement Scenario
- 7.5.3.6. Brazil Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Target Disease Prevalence
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Regulatory Framework
- 7.5.4.5. Reimbursement Scenario
- 7.5.4.6. Mexico Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.5.5. Argentina
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Target Disease Prevalence
- 7.5.5.3. Competitive Scenario
- 7.5.5.4. Regulatory Framework
- 7.5.5.5. Reimbursement Scenario
- 7.5.5.6. Argentina Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.6. MEA
- 7.6.1. SWOT Analysis
- 7.6.2. MEA Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.6.3. South Africa
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Regulatory Framework
- 7.6.3.5. Reimbursement Scenario
- 7.6.3.6. South Africa Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.6.4. Saudi Arabia
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Regulatory Framework
- 7.6.4.5. Reimbursement Scenario
- 7.6.4.6. Saudi Arabia Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.6.5. UAE
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Regulatory Framework
- 7.6.5.5. Reimbursement Scenario
- 7.6.5.6. UAE Insulin Storage Device Market, 2018 - 2030 (USD Million)
- 7.6.6. Kuwait
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Target Disease Prevalence
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Regulatory Framework
- 7.6.6.5. Reimbursement Scenario
- 7.6.6.6. Kuwait Insulin Storage Device Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Share Analysis, 2022
- 8.4. Company Profiles/Listing
- 8.4.1. ReadyCare, LLC
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Type benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. DISONCARE
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Type benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Medicool
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Type benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Cooluli, Arkray, Inc.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Type benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Arkray, Inc.
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Type benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Zhengzhou Olive Electronic Technology Co. Ltd.
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Type benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Zhengzhou Defrigus Electric Device Co., LtdC
- 8.4.7.1. ompany overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Type benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. COOL Sarl-FR
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Type benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Godrej Appliances
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Type benchmarking
- 8.4.9.4. Strategic initiatives